GDF15 Analogues Acting as GFRAL Ligands
ChemMedChem · 05.05.2025 · 20 (9)
DOI: 10.1002/cmdc.202400961 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 17.02.2025. Verfasst von Andrea Di Santo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Psychology, Pharmacology and Infant Health, Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology,…. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Glial Cell Line-Derived Neurotrophic Factor Receptors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Growth differentiation factor 15 (GDF15) is a TGF‐β superfamily member involved in diverse physiological and pathological processes. It is expressed in various tissues and its circulating levels rise during exercise, aging, pregnancy, and conditions such as cancer, cardiovascular disease, and infections. The biological activities of GDF15, including anorexia and cachexia, are primarily mediated through the GFRAL receptor, localized in the brainstem and functioning via RET co‐receptor recruitment. This signaling is crucial for energy homeostasis and nausea induction. Recent studies suggest a broader GFRAL distribution, potentially explaining GDF15′s distinct roles. These findings sparked interest in leveraging GDF15‐GFRAL pathways for therapeutic development. Two primary strategies include GDF15 analogues as GFRAL agonists for obesity treatment and GDF15‐derived peptides as antagonists to counteract cancer‐induced cachexia and related disorders. This review highlights advancements in understanding GDF15‐GFRAL signaling and its implications, summarizing bioactive GDF15‐derived molecules, their pharmacological applications, and offering insights into novel treatment avenues for GDF15‐associated conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Psychology, Pharmacology and Infant Health, Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, University of, Florence, Via Ugo Schiff, 6, Sesto Fiorentino, FI, 500…
- Department of Health Science, Psychiatry Unit, University of Florence, Largo Brambilla 3, Florence, FI, 50134, Italy.
- Department of Health Science, Anesthesiology Unit, University of Florence, Largo Brambilla 3, Florence, FI, 50134, Italy.
- Department of Experimental and Clinical Medicine, Section of Physiological Sciences, University of Florence, Viale Morgagni 63, Florence, FI, 50134, Italy.
- Department of Chemistry "Ugo Schiff", Interdepartmental Research, Unit of Peptide and Protein Chemistry and Biology, University of, Florence, via della Lastruccia, 3-13, Sesto Fiorentino, FI, 50019, Italy.
- Institute of Chemistry of Organometallic Compounds -, National, Research Council of Italy (ICCOM-CNR), Via Madonna del Piano, 10, Sesto Fiorentino, FI, 50019, Florence, Italy.
ORCID-Profile: Paolo Rovero
Zitieren
APA
Di Santo, A., Tarchi, L., Villa, G., Castellini, G., Ricca, V., Squecco, R., Papini, A. M., Real-Fernandez, F., & Rovero, P. (2025). GDF15 Analogues Acting as GFRAL Ligands. ChemMedChem, 20(9). https://doi.org/10.1002/cmdc.202400961
Vancouver
Di Santo A, Tarchi L, Villa G, Castellini G, Ricca V, Squecco R, et al. GDF15 Analogues Acting as GFRAL Ligands. ChemMedChem. 2025;20(9). doi:10.1002/cmdc.202400961
BibTeX
@article{DiSanto2025,
author = {Di Santo, Andrea and Tarchi, Livio and Villa, Gianluca and Castellini, Giovanni and Ricca, Valdo and Squecco, Roberta and Papini, Anna Maria and Real-Fernandez, Feliciana and Rovero, Paolo},
title = {GDF15 Analogues Acting as GFRAL Ligands},
journal = {ChemMedChem},
year = {2025},
volume = {20},
number = {9},
doi = {10.1002/cmdc.202400961}
}
EUVIMED